Abstract:For infectious diseases, rapid and accurate identification of the pathogen is critical for effective management and treatment, but diagnosis remains challenging, particularly in resource-limited areas. Methods that accurately detect pathogen nucleic acids can provide robust, accurate, rapid, and ultrasensitive technologies for point-of-care diagnosis of pathogens, and thus yield information that is invaluable for disease management and treatment. Several technologies, mostly PCR-based, have been employed for pathogen detection; however, these require expensive reagents and equipment, and skilled personnel. CRISPR/Cas systems have been used for genome editing, based on their ability to accurately recognize and cleave specific DNA and RNA sequences. Moreover, following recognition of the target sequence, certain CRISPR/Cas systems including orthologues of Cas13, Cas12a, and Cas14 exhibit collateral nonspecific catalytic activities that can be employed for nucleic acid detection, for example by degradation of a labeled nucleic acid to produce a fluorescent signal. CRISPR/Cas systems are amenable to multiplexing, thereby enabling a single diagnostic test to identify multiple targets down to attomolar (10-18 mol/L) concentrations of target molecules. Developing devices that couple CRISPR/Cas with lateral flow systems may allow inexpensive, accurate, highly sensitive, in-field deployable diagnostics. These sensors have myriad applications, from human health to agriculture. In this review, we discuss the recent advances in the field of CRISPR-based biosensing technologies and highlight insights of their potential use in a myriad of applications.

Argonaute-Based Nucleic Acid Detection Technology: Advantages, Current Status, Challenges, and Perspectives

Argonaute protein-based nucleic acid detection technology

Emerging Argonaute-based nucleic acid biosensors

Programmable and ultra-efficient Argonaute protein-mediated nucleic acid tests: A review

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Argonaute with stepwise endonuclease activity promotes specific and multiplex nucleic acid detection

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Mesophilic Argonaute-Mediated Polydisperse Droplet Biosensor for Amplification-Free, One-Pot, and Multiplexed Nucleic Acid Detection Using Deep Learning

CRISPR Cas system: A strategic approach in detection of nucleic acids

Trends in the Use of Argonaute Proteins in Molecular Diagnosis

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

CRISPR/Cas and Argonaute-powered lateral flow assay for pathogens detection

CRISPR-induced DNA reorganization for multiplexed nucleic acid detection